FOOT & ANKLE
AAOS 2016: High-dose hyaluronate reduces pain versus placebo for plantar fasciitis
168 patients with plantar fasciitis were randomized to injection therapy with either low-dose hyaluronate, high-dose hyaluronate, or placebo. Each treatment arm received five weekly injections of the allocated treatment, and was assessed for pain, the Roles and Maudsley score and activities of daily living (ADL) score each week. After 5 weeks, the high-dose hyaluronate group demonstrated a significantly greater reduction in pain from baseline than the placebo group. There was no significant difference between the low-dose hyaluronate group and placebo group for pain reduction after 5 weeks.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
